||This article contains content that is written like an advertisement. (April 2015)|
Cyberkinetics is an American company with roots tied to the University of Utah. It was co-founded by John Donoghue, Mijail Serruya, and Gerhard Friehs of Brown University and Nicho Hatsopoulos of the University of Chicago. The Braingate technology and related Cyberkinetic’s assets were acquired by Blackrock Microsystems, LLC in 2008. Blackrock Microsystems is a privately held company that provides enabling tools for the neuroscience, neural engineering, and neuroprosthetics research and clinical community worldwide.
Scientists behind the project used $9.3 million in first round funding led by Oxford Bioscience Partners. A 2002 merger with Bionic Technologies, co-founded by Brian Hatt and Richard Normann (the inventor of the Utah array) added to a tech team armed with intellectual property rights gained from Brown, MIT, and others. They say they're three to five years away from putting a product on the market.[when?]
According to their latest SEC filing, the Founders of the company resigned from the Board of Directors at the end of October, 2008.
Merger & Renaming
In late 2004, Cyberkinetics initiated a reverse merger with a Texas company in order to gain access to the public market. The resulting company was renamed Cyberkinetics Neurotechnology Systems, Inc. and its shares are listed under the symbol CYKN.OB. In 2009, the BrainGate business and related Cyberkinetic’s assets were sold to privately held Braingate, LLC.
Since July 8, 2009 clinical Trials are being conducted for the Brain Gate 2 Neural Interface System.
- "neuroscience research systems - empowering electrophysiology". blackrockmicro.com.
- Braingate gets a new lease on life, The Boston Globe, August, 2009
- "Blackrock Microsystems Obtains Expanded 510(k) to Market NeuroPort System". PRWeb. 15 July 2009.
- "BrainGate - Home". Braingate2.org.
- "BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia - Full Text View". ClinicalTrials.gov.